Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • INFY vs GSK✓SelectedUSD · GSKINFY vs GSK performance historyLatest closeAs of+3.26%11/20
Stock and ETF performance explorer

INFY vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-39.8%
GSK return
+40.7%
Excess return
-80.5%
Maximum drawdown
-54.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+3.3%-0.1%+3.4%+3.3%
7D-2.1%-5.3%+3.2%-1.0%
30D-5.6%-3.7%-2.0%-5.0%
3M+1.7%-7.3%+8.9%+3.1%
6M-3.8%-4.2%+0.5%-2.9%
YTD-31.0%+0.9%-31.9%-31.1%
1Y-28.3%+7.3%-35.5%-29.0%
3Y-25.6%+52.7%-78.3%-31.1%
All-39.8%+40.7%-80.5%-46.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling